−1.62USD
−82.31 MUSD
1.13 BUSD
49.13 M
About Prestige Consumer Healthcare Inc.
Sector
CEO
Ronald M. Lombardi
Headquarters
Tarrytown
Website
Employees (FY)
560
Founded
1996
ISIN
US74112D1019
FIGI
BBG000QM0RZ4
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PBH is 69.67 USD — it has increased by 1.93% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Prestige Consumer Healthcare Inc. stocks are traded under the ticker PBH.
Prestige Consumer Healthcare Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
PBH stock is 2.62% volatile and has beta coefficient of 0.58. Check out the list of the most volatile stocks — is Prestige Consumer Healthcare Inc. there?
One year price forecast for Prestige Consumer Healthcare Inc. has a max estimate of 84.00 USD and a min estimate of 65.00 USD.
PBH earnings for the last quarter are 1.07 USD per share, whereas the estimation was 1.07 USD resulting in a 0.26% surprise. The estimated earnings for the next quarter are 1.04 USD per share. See more details about Prestige Consumer Healthcare Inc. earnings.
Prestige Consumer Healthcare Inc. revenue for the last quarter amounts to 286.32 M USD despite the estimated figure of 285.22 M USD. In the next quarter revenue is expected to reach 280.25 M USD.
Yes, you can track Prestige Consumer Healthcare Inc. financials in yearly and quarterly reports right on TradingView.
PBH stock has risen by 1.25% compared to the previous week, the month change is a 5.15% fall, over the last year Prestige Consumer Healthcare Inc. has showed a 13.21% increase.
PBH net income for the last quarter is 53.05 M USD, while the quarter before that showed 53.56 M USD of net income which accounts for −0.96% change. Track more Prestige Consumer Healthcare Inc. financial stats to get the full picture.
Today Prestige Consumer Healthcare Inc. has the market capitalization of 3.39 B, it has decreased by 1.90% over the last week.
No, PBH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PBH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Prestige Consumer Healthcare Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 560.00 employees. See our rating of the largest employees — is Prestige Consumer Healthcare Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Prestige Consumer Healthcare Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Prestige Consumer Healthcare Inc. stock shows the buy signal. See more of Prestige Consumer Healthcare Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Prestige Consumer Healthcare Inc. future price: according to them, PBH price has a max estimate of 84.00 USD and a min estimate of 65.00 USD. Read a more detailed Prestige Consumer Healthcare Inc. forecast: see what analysts think of Prestige Consumer Healthcare Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Prestige Consumer Healthcare Inc. EBITDA is 384.62 M USD, and current EBITDA margin is 34.29%. See more stats in Prestige Consumer Healthcare Inc. financial statements.